Tenacia Biopharmaceuticals and Golden Age Health Partner to Commercialize ZTALMY® for CDKL5 Deficiency Disorder in Mainland China
First-ever approved treatment for CDD in China now set for commercial launch through dedicated rare disease platform SHANGHAI–(BUSINESS WIRE)–Tenacia Biopharmaceuticals (Shanghai) Co., Ltd. (“Tenacia“) and GOLDEN AGE HEALTH (SHANGHAI) CO., LTD., a subsidiary of Golden Age Health Pte. Ltd. (collectively, “GAH“) today announced a Commercialization Agreement granting GAH exclusive rights to commercialize ZTALMY® (泽元安), the … [Read more…]
